The Synthetic Standard
Tuesday, June 17th, 2025
Daily Artificial Intelligence
Loading...

More

Yankees Place Aaron Judge on 10-Day IL with Toe Injury 2:11AM
PGA Tour Announces Shock Reconciliation with Saudi-Backed LIV Golf and DP World Tour 2:08AM
Top Stories This Week in Essex County: From Caldwells to Montclair 6:13PM
Debt Ceiling Talks Hit a Snag, Negotiations Paused Between White House and House Republicans 3:57PM
Blue Origin Wins NASA Contract to Develop Crewed Lunar Lander for Artemis Program 2:40PM
D.C. Police Lieutenant Indicted for Obstruction and Making False Statements in Connection with Proud Boys Leader 1:58PM
Denver Business Journal Announces Small Business Awards Finalists and Winner 1:31PM
Tesco Chairman John Allan Resigns Amid Allegations of Inappropriate Behaviour 1:16PM
Morgan Stanley CEO James Gorman to Step Down, Succession Race Begins 12:42PM
Foot Locker Shares Plummet 25% as Company Cuts Annual Forecasts 11:47AM
The Synthetic Standard
Stay up to date with the latest stories

Get a daily newsletter delivered straight to your inbox with the top stories of the day.

Publication

  • About
  • Staff
  • Archive
  • Contact

Legal

  • Privacy Policy
  • Terms & Conditions

The content on this site was not created under human supervision. No warranty, express or implied, is made as to the truth, accuracy, or completeness of the information provided. Readers are advised to verify any information independently before relying on it.

© 2025 The Synthetic Standard. All Rights Reserved.

Twitter page
April 8, 2023

Federal Judge Bars FDA from Changing Availability of Abortion Drug Mifepristone, Texas Ruling Halts Approval

Mattie McKinney
Mattie McKinney

A federal judge in Washington state has issued a ruling that prevents the Food and Drug Administration (FDA) from altering the availability of abortion drug mifepristone. This decision came almost simultaneously with another separate opinion by a federal judge who ruled to block the approval of the same drug after seven days.

Attorneys representing twelve Democratic state attorneys general had filed a lawsuit against the FDA back in February, alleging that the agency was not doing enough to ensure accessibility to mifepristone. In response, a federal judge in Texas recently issued an order halting any further approval for this widely used abortion pill which has been available on American markets for nearly 25 years.

This recent development places Texas at center stage yet again within America's ongoing abortion debate. The consequential ruling could potentially impact access to abortions as far away as New York State while threatening both FDA's authority over approving drugs and overall access to safe abortions nationwide.

Legal experts are keeping an eye on how these events progress through courts since there is still time before any definitive verdict is reached. If appeals court denies request for stay concerning Kacsmaryk's injunction, it may bring about legal challenges reaching all way up Supreme Court level where ultimate resolution might be found.

"The rulings made thus far have created uncertainty around women's reproductive rights," said Dr. Sarah Richardson-Grant, MD., obstetrician-gynecologist based out of Seattle "and we must make sure everyone involved understands potential consequences regarding health care decisions."

Advocates fighting for better accessibility continue their work despite setbacks caused by differing judicial opinions across different states like Washington or Texas—hoping eventually gain ground ensuring equal rights regardless one’s location within country.